Literature DB >> 23743052

Breast MRI of pure ductal carcinoma in situ: sensitivity of diagnosis and influence of lesion characteristics.

Astrid Baur1, Sonja D Bahrs, Sina Speck, Beate M Wietek, Bernhard Krämer, Ulrich Vogel, Claus D Claussen, Katja C Siegmann-Luz.   

Abstract

OBJECTIVES: The purpose of the study was to evaluate the sensitivity of breast MRI in the detection of pure DCIS and to analyze the influence of lesion type and nuclear grade.
METHODS: 58 consecutive patients with pathologically proven pure DCIS and preoperatively performed breast MRI were retrospectively reviewed and analyzed. Sensitivities in the detection of DCIS were calculated for MRI and mammography (Mx). Influence of MRI lesion type and nuclear grading on DCIS diagnosis was evaluated.
RESULTS: MRI detected pure DCIS with a sensitivity of 79.3%. The sensitivity of Mx was lower (69%), but the difference was not statistically significant (p=0.345). 46.2% of the DCIS presented as enhancing mass and 53.8% as non-mass-like enhancement (NMLE). None of the masses but 21.4% (n=6) of the NMLE were underestimated as probably benign (BI-RADS 3). MRI measured lesion sizes showed a moderate correlation (r=0.74) with histopathologically measured lesion sizes. MRI detection rate of DCIS decreased significantly (p=0.0458) with increasing nuclear grade. Calculated sensitivities were 100% for low-grade DCIS, 84.6% for intermediate-grade DCIS, and 66.7% for high-grade DCIS.
CONCLUSIONS: In this study MRI could detect pure DCIS more sensitively than Mx. Despite of missing statistically significance preoperative MRI seems to be helpful in patients with DCIS who are eligible for breast conservation. This applies in particular to patients with non-high-grade DCIS because those were significantly more often positive on MRI and significantly more often negative on Mx. Misinterpretation occurs especially in cases of NMLE and high-grade DCIS and therefore a correlation with Mx is also recommended.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast; Carcinoma in situ; Intraductal; Magnetic resonance imaging; Noninfiltrating

Mesh:

Year:  2013        PMID: 23743052     DOI: 10.1016/j.ejrad.2013.05.002

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  13 in total

Review 1.  [Diagnostic imaging of breast cancer : An update].

Authors:  M Funke
Journal:  Radiologe       Date:  2016-10       Impact factor: 0.635

2.  The Impact of Preoperative Breast MRI on Surgical Management of Women with Newly Diagnosed Ductal Carcinoma In Situ.

Authors:  Diana L Lam; Jacob Smith; Savannah C Partridge; Adrienne Kim; Sara H Javid; Daniel S Hippe; Constance D Lehman; Janie M Lee; Habib Rahbar
Journal:  Acad Radiol       Date:  2019-07-05       Impact factor: 3.173

3.  Towards optimal treatment of ductal carcinoma in situ.

Authors:  Christina Choy; Kefah Mokbel
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study.

Authors:  Tomoyuki Fujioka; Kazunori Kubota; Akira Toriihara; Youichi Machida; Kaori Okazawa; Tsuyoshi Nakagawa; Yukihisa Saida; Ukihide Tateishi
Journal:  World J Radiol       Date:  2016-08-28

5.  Accuracy of 3 T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS.

Authors:  Habib Rahbar; Wendy B DeMartini; Amie Y Lee; Savannah C Partridge; Sue Peacock; Constance D Lehman
Journal:  Eur J Radiol       Date:  2015-01-08       Impact factor: 3.528

Review 6.  The accuracy of magnetic resonance imaging in predicting the size of pure ductal carcinoma in situ: a systematic review and meta-analysis.

Authors:  Ricardo Roque; Mariana Robalo Cordeiro; Mónica Armas; Francisco Caramelo; Filipe Caseiro-Alves; Margarida Figueiredo-Dias
Journal:  NPJ Breast Cancer       Date:  2022-06-29

7.  Clinics in diagnostic imaging (180). Ductal carcinoma in situ (DCIS).

Authors:  Eu Jin Tan; Tammy Hui Lin Moey; Preetha Madhukumar; Lester Chee Hao Leong
Journal:  Singapore Med J       Date:  2017-10       Impact factor: 1.858

8.  Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).

Authors:  Carlos Canelo-Aybar; Alvaro Taype-Rondan; Jessica Hanae Zafra-Tanaka; David Rigau; Axel Graewingholt; Annette Lebeau; Elsa Pérez Gómez; Paolo Giorgi Rossi; Miranda Langendam; Margarita Posso; Elena Parmelli; Zuleika Saz-Parkinson; Pablo Alonso-Coello
Journal:  Eur Radiol       Date:  2021-05-30       Impact factor: 5.315

9.  Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).

Authors:  Shinn-Huey S Chou; Justin Romanoff; Constance D Lehman; Seema A Khan; Ruth Carlos; Sunil S Badve; Jennifer Xiao; Ralph L Corsetti; Sara H Javid; Derrick W Spell; Linda K Han; Jennifer L Sabol; John R Bumberry; Ilana F Gareen; Bradley S Snyder; Constantine Gatsonis; Lynne I Wagner; Antonio C Wolff; Kathy D Miller; Joseph A Sparano; Christopher E Comstock; Habib Rahbar
Journal:  Radiology       Date:  2021-08-03       Impact factor: 29.146

10.  Features of Undiagnosed Breast Cancers at Screening Breast MR Imaging and Potential Utility of Computer-Aided Evaluation.

Authors:  Mirinae Seo; Nariya Cho; Min Sun Bae; Hye Ryoung Koo; Won Hwa Kim; Su Hyun Lee; Ajung Chu
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.